about
Deep brain stimulation.Customized, miniature rapid-prototype stereotactic frames for use in deep brain stimulator surgery: initial clinical methodology and experience from 263 patients from 2002 to 2008.Deep brain stimulation modulates nonsense-mediated RNA decay in Parkinson's patients leukocytesFunctional improvement after subthalamic stimulation in Parkinson's disease: a non-equivalent controlled study with 12-24 month follow up.Bee Venom Alleviates Motor Deficits and Modulates the Transfer of Cortical Information through the Basal Ganglia in Rat Models of Parkinson's Disease.Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson's disease.Statistical power of studies examining the cognitive effects of subthalamic nucleus deep brain stimulation in Parkinson's disease.Targets for deep brain stimulation in Parkinson's disease.Underlying neurobiology and clinical correlates of mania status after subthalamic nucleus deep brain stimulation in Parkinson's disease: a review of the literatureSTN DBS of Advanced Parkinson's Disease Experienced in a Specialized Monitoring Unit with a Prospective ProtocolParkinson's disease: recent development in therapies for advanced disease with a focus on deep brain stimulation (DBS) and duodenal levodopa infusion.Electrode displacement after intracerebral hematoma as a complication of a deep brain stimulation procedure.Electrical stimulation for the treatment of epilepsy.Moving forward: advances in the treatment of movement disorders with deep brain stimulation.Adverse events associated with deep brain stimulation for movement disorders: analysis of 510 consecutive cases.Movement disorders and neuromodulation.Management of a DBS system in patients with traumatic brain injury: case report.Neuropsychological effects of bilateral deep brain stimulation of the subthalamic nucleus in Parkinson's disease.Neurochemical mechanisms induced by high frequency stimulation of the subthalamic nucleus: increase of extracellular striatal glutamate and GABA in normal and hemiparkinsonian rats.Delayed cerebritis after bilateral stereotactic implantation of globus pallidus interna electrodes for treatment of dystonia.Differential effects of prolonged high frequency stimulation and of excitotoxic lesion of the subthalamic nucleus on dopamine denervation-induced cellular defects in the rat striatum and globus pallidus.High-Frequency Stimulation of the Subthalamic Nucleus Blocks Compulsive-Like Re-Escalation of Heroin Taking in Rats.General anaesthesia for deep brain stimulator electrode insertion in Parkinson's disease.Side-effects of subthalamic stimulation in Parkinson's disease: clinical evolution and predictive factors.Automatic microelectrode recording analysis and visualization of the globus pallidus interna and stereotactic trajectory.Progression of Parkinson's disease following thalamic deep brain stimulation for tremor.Towards unambiguous reporting of complications related to deep brain stimulation surgery: A retrospective single-center analysis and systematic review of the literature
P2860
Q31044320-AEDEF4EA-B018-477D-B37E-EC0748DF467DQ34515608-E860E623-AED8-43DF-8526-5B0618204E68Q34831484-2F0DABE3-4F04-4559-86B3-43A461343D63Q35487919-46D52671-F3F1-46D8-82BC-142C29320E86Q35842101-A3560D59-155D-4999-919B-6CE6F54BBEC5Q36142291-A1185BA0-884B-4F7C-865C-E10B2DDEC0C1Q36360830-D6C435ED-E3F3-43F6-B252-DBC586AA1E25Q36481041-69E6AAB1-927B-464E-87C3-13B80A997E7FQ36605607-315A9B66-9433-4632-9FBA-26ECC478DD1AQ36986143-84774E1E-75C6-4BFB-9BEE-AEE85136FB7EQ37086136-57432E35-5504-402C-8A2A-49C386DF4861Q37224549-4D2F1D18-C437-432F-BC46-7EA22A3C89F4Q37426943-5BD3C32D-24B6-4553-8F1B-54031E84720FQ37956311-C95EA820-60F2-4C56-91FB-314702C6C77DQ38323116-B695D571-92C0-46F9-A290-7FC647489E2CQ39539487-7A3799C1-B6D0-4ED0-8C4F-743CDDC90CD0Q39698350-CC37219E-BEA6-4C80-9C3F-C6A541469C53Q40251148-A8D81C7E-ACFE-42E2-87D0-632B1C4EB366Q42454736-85C2A491-18BC-487B-A62D-D2076B393BB7Q43223478-C59768A3-38B1-45A2-9EAF-D8829E1DDF3BQ45194977-D40CFDF4-1B8C-499A-8F85-70D5AA75B8ABQ48180715-E31ACF87-B784-458B-A7EF-65D04BA939A5Q48302151-FF07460E-84E3-4048-9DAC-D39553B04812Q48438662-5EEE9DF1-D348-43DD-9A99-6D16776E2E61Q48512918-41B05E75-B0CA-4D6D-BE95-0638E4FA58FFQ48619413-A2776C28-CDCE-4E04-8F1C-20E900EE6312Q58803855-8CBB302E-5304-4331-8989-A7E429C168CD
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Treatment results: Parkinson's disease.
@ast
Treatment results: Parkinson's disease.
@en
Treatment results: Parkinson's disease.
@nl
type
label
Treatment results: Parkinson's disease.
@ast
Treatment results: Parkinson's disease.
@en
Treatment results: Parkinson's disease.
@nl
prefLabel
Treatment results: Parkinson's disease.
@ast
Treatment results: Parkinson's disease.
@en
Treatment results: Parkinson's disease.
@nl
P2093
P2860
P50
P356
P1433
P1476
Treatment results: Parkinson's disease.
@en
P2093
Adnan Koudsie
Alexandre Mendes
Stephan Chabardes
P2860
P304
P356
10.1002/MDS.10146
P407
P478
17 Suppl 3
P577
2002-01-01T00:00:00Z